Circulation · 2011 · 117 citations · 29 references
MedicineCardiologyInternal MedicineClinical CardiologyClinical EpidemiologyEpidemiologyCardiac BiomarkersCardiac Risk AssessmentCardiovascular DiseaseCardiovascular RiskCoronary Artery DiseaseDiabetes MellitusCardiac TroponinsCardiovascular Disease IncidenceCardiovascular Risk DetectionCoronary Heart Disease EpidemiologyDiabetes-associated Cardiac RiskHigh-sensitivity Troponin AssaysTroponin Elevation
BACKGROUND: Very low levels of cardiac troponin T are associated with an increased risk of cardiovascular death in patients with stable chronic coronary disease. Whether high-sensitivity cardiac troponin T levels are associated with adverse cardiovascular outcomes in individuals without cardiovascular disease (CVD) has not been well studied. METHODS AND RESULTS: Using 2 complementary study designs, we evaluated the relationship between baseline cardiac troponin and incident CVD events among diabetic and nondiabetic participants in the Women's Health Study (median follow-up, 12.3 years). All diabetic women with blood specimens were included in a cohort study (n=512 diabetic women, n=65 events), and nondiabetic women were sampled for inclusion in a case-cohort analysis (n=564 comprising the subcohort, n=479 events). High-sensitivity cardiac troponin T was detectable (≥ 0.003 μg/L) in 45.5% of diabetic women and 30.3% of nondiabetic women (P<0.0001). In models adjusted for traditional risk factors and hemoglobin A(1c), detectable high-sensitivity cardiac troponin T was associated with subsequent CVD (myocardial infarction, stroke, cardiovascular death) in diabetic women (adjusted hazard ratio, 1.79; 95% confidence interval, 1.04 to 3.07, P=0.036) but not nondiabetic women (adjusted hazard ratio, 1.13; 95% confidence interval, 0.82 to 1.55; P=0.46). Further adjustment for amino-terminal pro-B-type natriuretic peptide and estimated renal function did not substantially alter this relationship among diabetic women (hazard ratio, 1.76; 95% confidence interval, 1.00 to 3.08; P=0.0499), which appeared to be driven by a 3-fold increase in CVD death that was not observed in nondiabetic women. CONCLUSIONS: Very low but detectable levels of cardiac troponin T are associated with total CVD and CVD death in women with diabetes mellitus. Among healthy nondiabetic women, detectable compared with undetectable troponin was not associated with CVD events.
29
Effects of Intensive Glucose Lowering in Type 2 Diabetes
New England Journal of Medicine · 2008 · 7.9K citations · Full text
Medicine, Endocrinology, Physiology +14
Jessica M. Sontrop, Stephanie N. Dixon, Amit X. Garg et al. · American Journal of Nephrology · 2013 · 5.9K citations · Full text
Universal Definition of Myocardial Infarction
Kristian Thygesen, Joseph S. Alpert, Harvey D. White · Circulation · 2007 · 4.2K citations